Target |
Mechanism IRAK1 antagonists [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 1/2 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism IRAK1 antagonists [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target- |
Mechanism IRAK1 antagonists [+1] |
Active Org. ![]() |
Originator Org.- |
Active Indication |
Inactive Indication- |
Drug Highest PhaseIND Approval |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date12 Sep 2022 |
Sponsor / Collaborator |
Start Date14 Sep 2020 |
Sponsor / Collaborator |